Knowledge Hub | Nice Insight

Subscribe

Knowledge Hub
Pharma’s Almanac

Mobile Navigation

Subscribe for the Newsletter

Loading…

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Subscribe for the newsletter

Advanced Therapies
Traditional Biologics
Sterile Fill/Finish
Oral Solid Dose
Small Molecule – API

Topics & Trends

Capacity
Market
Manufacturing
Development
Analytical
Regulatory
Investment
Talent
Technology

Mammalian Cell Culture, Biologics
Microbial Fermentation, Biologics
Antibody-Drug Conjugate, ADC
Sterile Fill Finish
Gene Therapy
Messenger Ribonucleic Acid, mRNA
Plasmids
Active Pharmaceutical Ingredients, API
Oral Solid Dose, OSD

State of the industry

2026 State of the Industry
2025 State of the Industry

© 2026 PHARMA’S ALMANAC. All rights reserved.

Privacy Policy Terms And Conditions

STAGING

Loading…

Knowledge Hub

Sort By

Mobile Filter Sidebar

1 / 1

The Next Productivity Leap in Mammalian Cell Culture

Productivity

The Next Productivity Leap in Mammalian Cell Culture

Pharma's Almanac

PAO-09-26-PA-03Sep 3, 2026

The Case for Earlier CDMO Involvement in Drug Development

Development CDMO

The Case for Earlier CDMO Involvement in Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-09-26-PA-02Sep 2, 2026

Digital Twins vs. Traditional Scale-Up Models: Which Approach Is Better for Bioprocess Development?

Pathfinder

Digital Twins vs. Traditional Scale-Up Models: Which Approach Is Better for Bioprocess Development?

Nice Insight

PAO-26-PF-22Aug 28, 2026

An Unnatural Phenomenon: How Synthetic Biology May Disrupt Pharma and Beyond

Synthetic Biology

An Unnatural Phenomenon: How Synthetic Biology May Disrupt Pharma and Beyond

Nigel Walker

Nice Insight

PAO-06-21-NI-02Jun 10, 2021

1 / 1